ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1052

A Wolf in Sheep's Clothing: Visceral Kaposi Sarcoma Masquerading as Post-Transplant Lymphoproliferative Disorder After Kidney Transplantation

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Parmar, Parth Pravinchandra, University of Florida, Gainesville, Florida, United States
  • Mehta, Rohan V., University of Florida, Gainesville, Florida, United States
  • Gajjar, Prachi, University of Florida, Gainesville, Florida, United States
  • Kumar, Sameet, University of Florida, Gainesville, Florida, United States
  • Schamber, Logan Nguyen, University of Florida, Gainesville, Florida, United States
  • Joseph, Megan S., University of Florida, Gainesville, Florida, United States
Introduction

Kaposi sarcoma (KS) is a human herpesvirus-8 (HHV-8)–associated angioproliferative neoplasm. It has 400–500-fold higher incidence in kidney transplant recipients (KTR), especially with calcineurin inhibitors use. Prognosis is worse with visceral involvement.

Case Description

A 71-year-old male with deceased donor kidney transplantation (KT), antithymocyte globulin induction and tacrolimus/mycophenolate maintenance presented one year post-KT with progressive renal failure, anasarca, and dialysis dependence. Allograft biopsy showed microvascular inflammation without rejection; steroids and immunoglobulin were ineffective. Imaging revealed retroperitoneal lymphadenopathy suspicious for post-transplant lymphoproliferative disorder (PTLD). Lymph node biopsy confirmed Kaposi sarcoma (KS) with HHV-8 LANA-1 positivity; EBER, CD30, and clonal B cells were negative, excluding PTLD. Bronchoscopy showed endobronchial lesions consistent with pulmonary KS. HHV-8 PCR was 121,000 copies/mL; ganciclovir was given until unquantifiable. Tacrolimus was switched to everolimus and liposomal doxorubicin was stopped after 2 cycles due to declining status, complicated by tracheostomy-dependent respiratory failure and ongoing dialysis.

Discussion

This case highlights visceral KS with high HHV-8 viremia mimicking PTLD without cutaneous lesions. Elevated HHV-8 with anasarca raised concern for KSHV-associated inflammatory cytokine syndrome. This underscores the importance of early tissue diagnosis, HHV-8 viral load assessment, and high suspicion in KTR with unexplained lymphadenopathy, supporting pre-transplant HHV-8 screening.

Violaceous lesion at the level of Carina seen on Bronchoscopy